PTC Therapeutics Overview
PTC Therapeutics Target Price
Analysts' 12-month price predictions for PTCT.
Share Price
$57.26
Average Target Price
$68.00
18.8% upside
18.8% upside2 analysts in the last 4 months
High: $70 | Low: $66
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-08 | Robert W. BairdJoel Beatty | $70 | 22.2% upside |  |
| 2025-05-07 | Robert W. BairdJoel Beatty | $66 | 15.3% upside | |
| 2025-01-07 | RBC CapitalBrian Abrahams | $58 | 1.3% upside | |
| 2024-11-27 | Robert W. BairdJoel Beatty | $52 |  9.2% downside | |
| 2024-10-11 | Morgan StanleyJeffrey Hung | $45 | 21.4% downside | |
| 2024-08-26 | UBSColin Bristow | $47 | 17.9% downside | |
| 2024-07-12 | Morgan StanleyJeffrey Hung | $32 | 44.1% downside | |
| 2024-05-20 | Goldman SachsPaul Choi | $32 | 44.1% downside | |
| 2024-05-20 | JefferiesKelly Shi | $46 | 19.7% downside | |
| 2024-04-26 | Morgan StanleyJeffrey Hung | $30 | 47.6% downside | |
| 2022-12-14 | Goldman Sachs | $35 | 38.9% downside | |
| 2022-06-23 | RBC CapitalBrian Abrahams | $46 | 19.7% downside | |
| 2022-04-05 | Cantor FitzgeraldKristen Kluska | $63 | 10% upside | |
| 2021-08-31 | UBSColin Bristow | $45 | 21.4% downside | |